Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma

Scientific Reports
Ji-Jin YaoYing Sun

Abstract

This study is to identify significant dosimetric parameters for ear disorders in nasopharyngeal carcinoma (NPC) patients treated with intensity modulated therapy only. Ninety-seven patients with NPC were retrospectively reviewed. Organs at risk (OARs) in the auditory apparatus were contoured. Dose-volume histogram parameters were generated for the Eustachian tube (ET), tympanic cavity (TC), mastoid air cells, vestibular apparatus, cochlea and internal auditory canal (IAC). Ear disorders were rated 0 (none), 1 (mild) or 2 (severe) by a clinician blinded to radiation doses; Grade 2 ear disorders was the study end-point. Multivariate analysis revealed ET.D30 (dose to 30% of ET volume) >52.75 Gy and M.D0.5CC (dose to 0.5 ml of mastoid volume) >41.04 Gy (OR = 3.77, P = 0.012 and OR = 1.27, P = 0.033, respectively) were associated with Grade 2 ear disorders. Our results demonstrated that post-irradiation ear disorders remain a common late toxicity in NPC after IMRT. ET.D30 and M.D0.5CC should be considered during IMRT treatment plan optimization, review and approval.

References

Dec 1, 1992·The Journal of Laryngology and Otology·N L TangC A van Hasselt
Aug 1, 1991·International Journal of Radiation Oncology, Biology, Physics·C GrauO Elbrønd
Jun 1, 1995·The Annals of Otology, Rhinology, and Laryngology·M M HsuK L Lin
Aug 1, 1997·International Journal of Radiation Oncology, Biology, Physics·R NishimuraM Takahashi
Nov 4, 1998·Auris, Nasus, Larynx·W K Low, K W Fong
Jan 16, 2004·Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·Oskar B Kujawski, Dennis S Poe
Apr 9, 2005·International Journal of Radiation Oncology, Biology, Physics·Charlie C PanPaul R Kileny
Jul 26, 2006·International Journal of Radiation Oncology, Biology, Physics·Franziska HerrmannThomas Herrmann
Jan 24, 2007·International Journal of Radiation Oncology, Biology, Physics·Niranjan BhandareWilliam M Mendenhall
Aug 19, 2008·International Journal of Radiation Oncology, Biology, Physics·Ying J HitchcockDennis C Shrieve
Oct 27, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Sheng Zi WangLei Wang
Sep 16, 2010·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Kai-Li LiangJiun-Yih Shiao
Feb 1, 2011·International Journal of Radiation Oncology, Biology, Physics·Gary V WalkerAnita Mahajan
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Apr 12, 2014·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Ying SunJun Ma

❮ Previous
Next ❯

Citations

Jan 24, 2019·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Ayca AntYusuf Kemal Kemaloglu
Dec 19, 2020·Journal of Applied Clinical Medical Physics·Hideki MinatogawaHiroki Shirato
Mar 16, 2021·Acta Oto-laryngologica·Gina NaSeong Hoon Bae

❮ Previous
Next ❯

Related Concepts

Related Feeds

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.